Pharmacokinetics and pharmacodynamics of methotrexate in non-neoplastic diseases.
about
Methotrexate for topical application in an extemporaneous preparation.What can clinicians learn from therapeutic studies about the treatment of acute oral methotrexate poisoning?Safety and efficacy of low-dose methotrexate for pediatric patients with steroid-refractory acute graft-versus-host disease after hematopoietic stem cell transplantation.Systemic methotrexate therapy for psoriasis: past, present and future.A phase I trial to evaluate the safety and pharmacokinetics of low-dose methotrexate as an anti-malarial drug in Kenyan adult healthy volunteers.A review of therapeutic challenges and achievements of methotrexate delivery systems for treatment of cancer and rheumatoid arthritis.Recent advances using immunomodulators for inflammatory bowel disease.Folate supplementation reduces the side effects of methotrexate therapy for psoriasis.The role and advances of immunomodulator therapy for inflammatory bowel disease.Methotrexate: an old new drug in autoimmune disease.Methotrexate: a gold standard for treatment of rheumatoid arthritis.Review article: The pharmacokinetics and pharmacodynamics of drugs used in inflammatory bowel disease treatment.Pharmacology and Optimization of Thiopurines and Methotrexate in Inflammatory Bowel Disease.Interaction of rhubarb and methotrexate in rats: in vivo and ex vivo approaches.Competing risks modeling of cumulative effects of time-varying drug exposures.Sequential optimization of methotrexate encapsulation in micellar nano-networks of polyethyleneimine ionomer containing redox-sensitive cross-links.Pharmacokinetics, pharmacodynamics and toxicities of methotrexate in healthy and collagen-induced arthritic rats.Simple and reliable HPLC method for the monitoring of methotrexate in osteosarcoma patients.Lumiracoxib does not affect methotrexate pharmacokinetics in rheumatoid arthritis patients.Synergistic effect of iontophoresis and soluble microneedles for transdermal delivery of methotrexate.Low-dose MTX for the treatment of acute and chronic graft-versus-host disease in children.Liquid chromatographic methods for the therapeutic drug monitoring of methotrexate as clinical decision support for personalized medicine: A brief review.Mitochondrial translation requires folate-dependent tRNA methylation.
P2860
Q30316265-9145ED24-798A-4CF4-9CBD-93C8424389EEQ30397448-CF0A462A-E08D-4F64-9ED0-8E8F6358FFBFQ33411063-28B41A8F-4061-41F7-A24E-267E3310F60AQ34356265-4E74A12B-8964-478A-9F6A-549E1FF333C8Q34770054-6E829464-ACD7-4BBE-8831-D9A1E7996805Q38071913-C6C410E7-4CC1-4B47-A06C-0080EA470000Q38081399-13074E5E-9F7F-4102-8036-CA893D1A5489Q38223934-8F79972D-6585-4D24-B842-B5D2890C3356Q38237701-7DC168FE-BE05-4997-BE7F-1B8392F8C52AQ38253237-FF088877-B3E3-4A57-B82A-A83936D33A91Q38260785-817B6D95-9DC2-4D5E-85E5-0A333A96394FQ38501680-7CCF11BC-1738-4FD3-AD6A-115D03A28998Q38563075-E98EACA6-2A1B-4FD1-B0EE-2E2B78744315Q39063274-80843E96-265A-45C9-897F-4BA3357384E5Q40053023-4E58054B-0307-4AD9-B967-CCAAAD9A2949Q40697198-21D9DF9F-D133-477F-96DF-68CC2DF0879EQ40772231-2B897933-1D43-4E72-8799-6C8F2CEA293FQ44252346-62DCD2D0-5CFB-4F9D-AE4D-6B5694B45AA3Q45038809-B26E7E46-FFE2-4B05-B3D9-759C7ED63A51Q46844120-45965AD6-9C89-48A9-BB54-B721D50391E0Q46890990-CCCAB182-5137-475D-B6D0-725211440A43Q47567325-479328C6-A908-4306-A08D-B88B35ACF844Q47648942-369A8202-C55D-4A00-84E4-89DE4D1F99BF
P2860
Pharmacokinetics and pharmacodynamics of methotrexate in non-neoplastic diseases.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Pharmacokinetics and pharmacodynamics of methotrexate in non-neoplastic diseases.
@ast
Pharmacokinetics and pharmacodynamics of methotrexate in non-neoplastic diseases.
@en
type
label
Pharmacokinetics and pharmacodynamics of methotrexate in non-neoplastic diseases.
@ast
Pharmacokinetics and pharmacodynamics of methotrexate in non-neoplastic diseases.
@en
prefLabel
Pharmacokinetics and pharmacodynamics of methotrexate in non-neoplastic diseases.
@ast
Pharmacokinetics and pharmacodynamics of methotrexate in non-neoplastic diseases.
@en
P2093
P1476
Pharmacokinetics and pharmacodynamics of methotrexate in non-neoplastic diseases.
@en
P2093
Jaroslav Chládek
Jirina Martínková
P304
P356
10.2165/00003088-200342020-00003
P577
2003-01-01T00:00:00Z
P5875
P6179
1018988219